US 8093286
Methods for treatment with bucindolol based on genetic targeting
granted A61PA61P25/06A61P25/22
Quick answer
US patent 8093286 (Methods for treatment with bucindolol based on genetic targeting) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P25/06, A61P25/22, A61P35/00, A61P43/00